Skip to main content
SpringerLink
Log in

Pituitary apoplexy and rivaroxaban

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Pituitary apoplexy (PA), defined by the occurrence of a massive hemorrhagic necrotic rearrangement within a pituitary adenoma, is rare. Its occurrence can be associated with certain risk factors, including anticoagulation. We report the first case of PA with rivaroxaban which is one of the new oral anticoagulants: a 73 year-old patient presenting with severe headache and visual field deterioration. Surgery was performed. Radiotherapy treatment was decided three months after surgery because of tumor residue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chatterjee S, Sardar P, Biondi-Zoccai G, Kumbhani D (2013) New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation. JAMA Neurol 70(12):1486–1490

    PubMed  Google Scholar 

  2. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361(12):1139–1151

    Article  CAS  PubMed  Google Scholar 

  3. Uemura M, Miyashita F, Shimomura R, Fujinami J, Toyoda K (2013) Pituitary apoplexy during treatment with dabigatran. Neurol Clin Neurosci 1:82–83

    Article  Google Scholar 

  4. Doglietto F, Costi E, Villaret AB, Mardighian D, Fontanella MM, Giustina A (2016) New oral anticoagulants and pituitary apoplexy. Pituitary 19(2):232‑4

    Article  Google Scholar 

  5. Doglietto F, Roca E, La Rocca G, Schreiber A, Bolzoni Villaret A, Nicolai P et al (2017) New oral anticoagulants and pituitary apoplexy. World Neurosurg 100:700

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CHU REIMS service endocrinologie, Reims, France

    S. Ly, A. Naman & B. Delemer

  2. CHU REIMS service radiologie, Reims, France

    B. Chaufour-Higel

  3. CHU REIMS service anatomopathologie, Reims, France

    M. Patey

  4. CHU REIMS service ophtalmologie, Reims, France

    C. Arndt

  5. CHU REIMS service neurochirurgie, Reims, France

    C. F. Litre

Authors
  1. S. Ly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Naman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Chaufour-Higel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Patey
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Arndt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B. Delemer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. F. Litre
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Ly.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ly, S., Naman, A., Chaufour-Higel, B. et al. Pituitary apoplexy and rivaroxaban. Pituitary 20, 709–710 (2017). https://doi.org/10.1007/s11102-017-0828-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-017-0828-4

Keywords

Search

Navigation